Corneal Crosslinking (CXL) is now FDA-approved and is an exciting treatment to help stop the progression of keratoconus and post-refractive surgery ectasia
Read More >

Brighton Vision Center surgeons participate in nationwide study expanding availability of corneas suitable for transplantation
Read More >

Complete MoisturePlus Multi Purpose Solution recalled due to acanthamoeba risk
Read More >

January was Glaucoma Awareness Month
Listen to Dr. Farjo's radio bulletin for the St. Joseph Mercy Hospital Medical Minute